Related Experiment Video
Updated: Jan 1, 2026

Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
Published on: October 23, 2018
DOCK5 regulates energy balance and hepatic insulin sensitivity by targeting mTORC1 signaling
Yerui Lai1, Anjiang Zhao2, Minghong Tan1
1Department of Endocrinology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Abstract:
The dedicator of cytokinesis 5 (DOCK5) is associated with obesity. However, the mechanism by which DOCK5 contributes to obesity remains completely unknown. Here, we show that hepatic DOCK5 expression significantly decreases at a state of insulin resistance (IR). Deletion of DOCK5 in mice reduces energy expenditure, promotes obesity, augments IR, dysregulates glucose metabolism, and activates the mTOR (Raptor)/S6K1 pathway under a high-fat diet (HFD). The overexpression of DOCK5 in hepatocytes inhibits gluconeogenic gene expression and increases the level of insulin receptor (InsR) and Akt phosphorylation. DOCK5 overexpression also inhibits mTOR/S6K1 phosphorylation and decreases the level of raptor protein expression. The opposite effects were observed in DOCK5-deficient hepatocytes. Importantly, in liver-specific Raptor knockout mice and associated hepatocytes, the effects of an adeno-associated virus (AAV8)- or adenovirus-mediated DOCK5 knockdown on glucose metabolism and insulin signaling are largely eliminated. Additionally, DOCK5-Raptor interaction is indispensable for the DOCK5-mediated regulation of hepatic glucose production (HGP). Therefore, DOCK5 acts as a regulator of Raptor to control hepatic insulin activity and glucose homeostasis.
Insights
Dedicator of cytokinesis 5 (DOCK5) regulates hepatic insulin activity and glucose homeostasis. Its deficiency promotes obesity and insulin resistance by activating the mTOR/S6K1 pathway.
Area of Science:
- Metabolism
- Molecular Biology
- Endocrinology
Background:
- Dedicator of cytokinesis 5 (DOCK5) is linked to obesity, but its functional mechanism is unclear.
- Hepatic DOCK5 expression declines during insulin resistance (IR).
Purpose of the Study:
- To elucidate the role of DOCK5 in regulating hepatic metabolism and insulin sensitivity.
- To investigate the molecular mechanisms underlying DOCK5's influence on obesity and glucose homeostasis.
Main Methods:
- Utilized DOCK5-deficient mice and hepatocytes under high-fat diet (HFD) conditions.
- Employed overexpression and knockdown strategies for DOCK5 in liver cells.
- Investigated the interaction between DOCK5 and Raptor using liver-specific Raptor knockout models and viral vectors (AAV8, adenovirus).
Main Results:
- DOCK5 deficiency in mice led to reduced energy expenditure, increased obesity, augmented IR, dysregulated glucose metabolism, and activated mTOR (Raptor)/S6K1 signaling under HFD.
- DOCK5 overexpression in hepatocytes suppressed gluconeogenic genes, enhanced insulin receptor (InsR) and Akt phosphorylation, and inhibited mTOR/S6K1 phosphorylation.
- DOCK5-Raptor interaction was essential for DOCK5's regulation of hepatic glucose production (HGP).
Conclusions:
- DOCK5 plays a critical role in maintaining hepatic insulin sensitivity and glucose homeostasis.
- DOCK5 functions by regulating the Raptor component of mTOR to control hepatic glucose metabolism.
- Targeting DOCK5 may offer a therapeutic strategy for obesity and related metabolic disorders.
More Related Videos
08:32Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
Published on: January 4, 2018
07:38Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Regulation of Metabolism
Insulin: The Receptor and Signaling Pathways
Regulation of Food Intake
The JAK-STAT Signaling Pathway